EpCAM overexpression has been linked to poor prognostic features, including larger tumor size, lymph node metastasis, and poor outcomes, as reported in a meta-analysis of gastric cancer studies by Dai et al. [34]. This evidence concerns the gene EPCAM and metastatic malignant neoplasm in the lymph nodes.